By Bruce Japsen | Deerfield-based medical product
giant Baxter International named Chief Financial Officer Robert Davis
president of the company’s renal business, and replaced him with a
long-time finance executive.

Davis, who becomes corporate vice president and president of Baxter’s
Renal Business, fills a position left open by the retirement of
30-year-veteran Bruce McGillivray. Meanwhile, Robert Hombach, previously
corporate vice president and treasurer, becomes corporate vice
president and chief financial officer.

“Both Rob and Bob have served successfully in a variety of leadership roles, and these new responsibilities further expand the breadth of their expertise,” Baxter chairman and chief executive officer Robert Parkinson said in a statement issued after the close of trading on the New York Stock Exchange.